Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma

Background: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, t...

Full description

Bibliographic Details
Main Authors: Ping-Kun Hsiao, Chia-Lun Chang, Kevin Sheng-Po Yuan, Alexander T.H. Wu, Szu-Yuan Wu
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/4/518
id doaj-725e40088d8c458190a3090896ce8911
record_format Article
spelling doaj-725e40088d8c458190a3090896ce89112020-11-24T22:11:29ZengMDPI AGJournal of Clinical Medicine2077-03832019-04-018451810.3390/jcm8040518jcm8040518Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary MacroadenomaPing-Kun Hsiao0Chia-Lun Chang1Kevin Sheng-Po Yuan2Alexander T.H. Wu3Szu-Yuan Wu4Department of General Surgery, Wan Fang Hospital, Taipei Medical University, Taipei 11031, TaiwanDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanDepartment of Otorhinolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, TaiwanPh.D. Program for Translational Medicine, Taipei Medical University, Taipei 11031, TaiwanDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanBackground: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, the patients were categorized into three groups according to the treatment modality: group 1, patients receiving modern FRT; group 2, patients receiving contemporary SRS; and group 3, patients receiving transsphenoidal surgery. Results: In total, 548 patients with nonfunctioning pituitary macroadenoma were selected for our study. Univariate and multivariate Cox regression analysis results indicated that the treatment modalities were significant independent prognostic factors. In multivariable Cox proportional hazard regression analysis, the adjusted hazard ratios (aHR; 95% confidence interval (CI)) of local recurrence were 0.27 (0.10–0.91) and 1.95 (1.25–2.37) for the SRS and transsphenoidal surgery cohorts, respectively, in comparison with the FRT cohort. The aHR (95% CI) of all-cause mortality was 1.03 (0.68–1.56) for the transsphenoidal surgery cohort in comparison with the FRT cohort, without statistical significance. However, the aHR (95% CI) of all-cause mortality was 0.36 (0.15–0.85) for the SRS cohort in comparison with the FRT cohort. Conclusion: Contemporary SRS has optimal effects on local recurrence and survival compared with modern FRT and transsphenoidal surgery. Modern FRT is associated with more favorable local control and equal survival compared with transsphenoidal surgery.https://www.mdpi.com/2077-0383/8/4/518nonfunctioning pituitary macroadenomatranssphenoidal surgerystereotactic radiosurgeryfractionated radiotherapyrecurrencemortality
collection DOAJ
language English
format Article
sources DOAJ
author Ping-Kun Hsiao
Chia-Lun Chang
Kevin Sheng-Po Yuan
Alexander T.H. Wu
Szu-Yuan Wu
spellingShingle Ping-Kun Hsiao
Chia-Lun Chang
Kevin Sheng-Po Yuan
Alexander T.H. Wu
Szu-Yuan Wu
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
Journal of Clinical Medicine
nonfunctioning pituitary macroadenoma
transsphenoidal surgery
stereotactic radiosurgery
fractionated radiotherapy
recurrence
mortality
author_facet Ping-Kun Hsiao
Chia-Lun Chang
Kevin Sheng-Po Yuan
Alexander T.H. Wu
Szu-Yuan Wu
author_sort Ping-Kun Hsiao
title Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
title_short Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
title_full Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
title_fullStr Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
title_full_unstemmed Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
title_sort results of treatment with modern fractionated radiotherapy, contemporary stereotactic radiosurgery, and transsphenoidal surgery in nonfunctioning pituitary macroadenoma
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-04-01
description Background: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, the patients were categorized into three groups according to the treatment modality: group 1, patients receiving modern FRT; group 2, patients receiving contemporary SRS; and group 3, patients receiving transsphenoidal surgery. Results: In total, 548 patients with nonfunctioning pituitary macroadenoma were selected for our study. Univariate and multivariate Cox regression analysis results indicated that the treatment modalities were significant independent prognostic factors. In multivariable Cox proportional hazard regression analysis, the adjusted hazard ratios (aHR; 95% confidence interval (CI)) of local recurrence were 0.27 (0.10–0.91) and 1.95 (1.25–2.37) for the SRS and transsphenoidal surgery cohorts, respectively, in comparison with the FRT cohort. The aHR (95% CI) of all-cause mortality was 1.03 (0.68–1.56) for the transsphenoidal surgery cohort in comparison with the FRT cohort, without statistical significance. However, the aHR (95% CI) of all-cause mortality was 0.36 (0.15–0.85) for the SRS cohort in comparison with the FRT cohort. Conclusion: Contemporary SRS has optimal effects on local recurrence and survival compared with modern FRT and transsphenoidal surgery. Modern FRT is associated with more favorable local control and equal survival compared with transsphenoidal surgery.
topic nonfunctioning pituitary macroadenoma
transsphenoidal surgery
stereotactic radiosurgery
fractionated radiotherapy
recurrence
mortality
url https://www.mdpi.com/2077-0383/8/4/518
work_keys_str_mv AT pingkunhsiao resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma
AT chialunchang resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma
AT kevinshengpoyuan resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma
AT alexanderthwu resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma
AT szuyuanwu resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma
_version_ 1725805379438247936